Am J Perinatol 2014; 31(10): 869-874
DOI: 10.1055/s-0033-1363499
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Changes in Fetal Heart Tracing Characteristics after Magnesium Exposure

Amanda M. Stewart
1   Department of Obstetrics and Gynecology, Washington University in St. Louis School of Medicine, St. Louis, Missouri
,
George A. Macones
2   Department of Obstetrics and Gynecology, Washington University in St. Louis, St. Louis, Missouri
,
Anthony O. Odibo
2   Department of Obstetrics and Gynecology, Washington University in St. Louis, St. Louis, Missouri
,
Ryan Colvin
2   Department of Obstetrics and Gynecology, Washington University in St. Louis, St. Louis, Missouri
,
Alison G. Cahill
2   Department of Obstetrics and Gynecology, Washington University in St. Louis, St. Louis, Missouri
› Author Affiliations
Further Information

Publication History

23 June 2013

04 November 2013

Publication Date:
17 December 2013 (online)

Abstract

Objective The aim of this study is to describe the changes in term fetal heart tracings after magnesium exposure.

Materials and Methods This was a retrospective cohort study of consecutive women delivering at a gestational age of ≥ 37 weeks with severe preeclampsia, receiving magnesium for seizure prophylaxis. Overall 90 minutes of electronic fetal monitoring (30 before magnesium, 30 during magnesium bolus, and 30 during steady state infusion) was prospectively interpreted by formally trained and blinded research nurses using American Congress of Obstetricians and Gynecologists guidelines. Multivariable analyses were performed using generalized estimating equations, comparing preexposure patterns to bolus, and steady state.

Results Out of the 238 women evaluated, an average decrease of 2.4 beats per minute (p = 0.02) was found after magnesium bolus. This persisted into the steady state (p < 0.01). Minimal/absent variability increased during bolus infusion (odds ratio [OR] 2.40, 95% confidence interval [CI] 1.10–5.62) but corrected by steady state (OR 1.44, 95% CI 0.76–2.80). There were no significant changes in the fetal heart rate (FHR) baseline < 120, tachycardia, or presence of accelerations or decelerations.

Conclusion Exposure to magnesium is associated with a transient decrease in variability and a clinically insignificant decrease in FHR baseline without an increased incidence in bradycardia or category change.

 
  • References

  • 1 Pryde PG, Mittendorf R. Contemporary usage of obstetric magnesium sulfate: indication, contraindication, and relevance of dose. Obstet Gynecol 2009; 114 (3) 669-673
  • 2 Lin CC, Pielet BW, Poon E, Sun G. Effect of magnesium sulfate on fetal heart rate variability in preeclamptic patients during labor. Am J Perinatol 1988; 5 (3) 208-213
  • 3 American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 106: Intrapartum fetal heart rate monitoring: nomenclature, interpretation, and general management principles. Obstet Gynecol 2009; 114 (1) 192-202
  • 4 Rotmensch S, Lev S, Kovo M , et al. Effect of betamethasone administration on fetal heart rate tracing: a blinded longitudinal study. Fetal Diagn Ther 2005; 20 (5) 371-376
  • 5 Kamitomo M, Sameshima H, Ikenoue T, Nishibatake M. Fetal cardiovascular function during prolonged magnesium sulfate tocolysis. J Perinat Med 2000; 28 (5) 377-382
  • 6 Wright JW, Ridgway LE, Wright BD, Covington DL, Bobitt JR. Effect of MgSO4 on heart rate monitoring in the preterm fetus. J Reprod Med 1996; 41 (8) 605-608
  • 7 Petrie RH, Yeh SY, Murata Y , et al. The effect of drugs on fetal heart rate variability. Am J Obstet Gynecol 1978; 130 (3) 294-299
  • 8 Hallak M, Martinez-Poyer J, Kruger ML, Hassan S, Blackwell SC, Sorokin Y. The effect of magnesium sulfate on fetal heart rate parameters: A randomized, placebo-controlled trial. Am J Obstet Gynecol 1999; 181 (5 Pt 1) 1122-1127
  • 9 Hiett AK, Devoe LD, Brown HL, Watson J. Effect of magnesium on fetal heart rate variability using computer analysis. Am J Perinatol 1995; 12 (4) 259-261
  • 10 Atkinson MW, Belfort MA, Saade GR, Moise Jr KJ. The relation between magnesium sulfate therapy and fetal heart rate variability. Obstet Gynecol 1994; 83 (6) 967-970
  • 11 Guzman ER, Conley M, Stewart R, Ivan J, Pitter M, Kappy K. Phenytoin and magnesium sulfate effects on fetal heart rate tracings assessed by computer analysis. Obstet Gynecol 1993; 82 (3) 375-379
  • 12 Cañez MS, Reed KL, Shenker L. Effect of maternal magnesium sulfate treatment on fetal heart rate variability. Am J Perinatol 1987; 4 (2) 167-170
  • 13 Stallworth JC, Yeh SY, Petrie RH. The effect of magnesium sulfate on fetal heart rate variability and uterine activity. Am J Obstet Gynecol 1981; 140 (6) 702-706
  • 14 Duffy CR, Odibo AO, Roehl KA, Macones GA, Cahill AG. Effect of magnesium sulfate on fetal heart rate patterns in the second stage of labor. Obstet Gynecol 2012; 119 (6) 1129-1136
  • 15 ACOG Committee on Practice Bulletins--Obstetrics. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol 2002; 99 (1) 159-167
  • 16 Twickler DM, McIntire DD, Alexander JM, Leveno KJ. Effects of magnesium sulfate on preterm fetal cerebral blood flow using Doppler analysis: a randomized controlled trial. Obstet Gynecol 2010; 115 (1) 21-25
  • 17 Cahill AG, Roehl KA, Odibo AO, Macones GA. Association and prediction of neonatal acidemia. Am J Obstet Gynecol 2012; 207 (3) e1-e8
  • 18 Nijhuis JG, Prechtl HF, Martin Jr CB, Bots RS. Are there behavioural states in the human fetus?. Early Hum Dev 1982; 6 (2) 177-195